- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Results
106
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
106 companies
Consun Pharmaceutical Group
Market Cap: HK$8.0b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.54
7D
8.3%
1Y
71.9%
China Shineway Pharmaceutical Group
Market Cap: HK$5.8b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong.
2877
HK$7.57
7D
0%
1Y
-18.6%
3SBio
Market Cap: HK$29.4b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$12.06
7D
6.9%
1Y
116.1%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in the People’s Republic of China, Hong Kong, and internationally.
1061
HK$4.11
7D
-0.7%
1Y
82.7%
Grand Pharmaceutical Group
Market Cap: HK$19.6b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.49
7D
-6.0%
1Y
38.6%
China Medical System Holdings
Market Cap: HK$17.9b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$7.24
7D
-1.4%
1Y
2.7%
Shanghai Haohai Biological Technology
Market Cap: HK$12.2b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$24.05
7D
3.2%
1Y
-11.7%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.09
7D
19.4%
1Y
127.2%
WuXi XDC Cayman
Market Cap: HK$40.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$30.85
7D
5.5%
1Y
76.3%
Pak Fah Yeow International
Market Cap: HK$710.5m
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.28
7D
5.1%
1Y
10.1%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.15
7D
4.5%
1Y
-4.2%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.22
7D
8.0%
1Y
110.3%
United Laboratories International Holdings
Market Cap: HK$24.3b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$12.80
7D
4.4%
1Y
33.5%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$360.0m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.32
7D
-8.6%
1Y
36.2%
SSY Group
Market Cap: HK$8.9b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.95
7D
-3.0%
1Y
-38.8%
Uni-Bio Science Group
Market Cap: HK$406.0m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.068
7D
9.7%
1Y
-26.1%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$946.8m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.67
7D
9.9%
1Y
-9.2%
Sino Biopharmaceutical
Market Cap: HK$66.6b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$3.61
7D
6.2%
1Y
46.7%
Alphamab Oncology
Market Cap: HK$6.7b
A clinical stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of oncology biologics.
9966
HK$6.56
7D
13.5%
1Y
53.6%
Lee's Pharmaceutical Holdings
Market Cap: HK$765.5m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.30
7D
6.6%
1Y
12.1%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.2b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.42
7D
-2.0%
1Y
-6.8%
Simcere Pharmaceutical Group
Market Cap: HK$19.6b
Engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China.
2096
HK$7.64
7D
-0.1%
1Y
48.3%
CSPC Pharmaceutical Group
Market Cap: HK$64.3b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.
1093
HK$5.43
7D
9.0%
1Y
-6.5%
WuXi Biologics (Cayman)
Market Cap: HK$85.8b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$20.20
7D
9.2%
1Y
51.7%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$469.8m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.28
7D
5.7%
1Y
81.8%
China Traditional Chinese Medicine Holdings
Market Cap: HK$9.9b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.94
7D
1.0%
1Y
-55.1%
JW (Cayman) Therapeutics
Market Cap: HK$616.0m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China.
2126
HK$1.42
7D
-0.7%
1Y
-16.5%
Hansoh Pharmaceutical Group
Market Cap: HK$131.4b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$21.85
7D
0.7%
1Y
38.5%
Modern Chinese Medicine Group
Market Cap: HK$216.0m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.38
7D
19.0%
1Y
17.2%
Shandong Xinhua Pharmaceutical
Market Cap: HK$8.5b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$5.42
7D
2.1%
1Y
2.3%
Viva Biotech Holdings
Market Cap: HK$3.0b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.35
7D
10.7%
1Y
203.4%
China Resources Pharmaceutical Group
Market Cap: HK$31.2b
An investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.85
7D
-2.0%
1Y
1.9%
Zhongzhi Pharmaceutical Holdings
Market Cap: HK$777.2m
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.
3737
HK$0.89
7D
-1.1%
1Y
-28.2%
CanSino Biologics
Market Cap: HK$10.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$28.65
7D
0.2%
1Y
58.8%
YiChang HEC ChangJiang Pharmaceutical
Market Cap: HK$10.1b
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
1558
HK$11.78
7D
25.9%
1Y
-7.8%
Innovent Biologics
Market Cap: HK$79.2b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$46.15
7D
9.4%
1Y
34.5%